Camidanlumab (HuMax-TAC) is a monoclonal antibody specifically targeting CD25, a cell-surface antigen prominently overexpressed in various hematological malignancies, while exhibiting minimal expression in normal tissues. This selective expression profile makes Camidanlumab an ideal candidate for the development of antibody-drug conjugates (ADCs) aimed at treating diseases such as lymphoma and leukemia. This antibody facilitates targeted therapeutic delivery, potentially enhancing treatment efficacy and reducing systemic toxicity.
Camidanlumab (HuMax-TAC) is a monoclonal antibody specifically targeting CD25, a cell-surface antigen prominently overexpressed in various hematological malignancies, while exhibiting minimal expression in normal tissues. This selective expression profile makes Camidanlumab an ideal candidate for the development of antibody-drug conjugates (ADCs) aimed at treating diseases such as lymphoma and leukemia. This antibody facilitates targeted therapeutic delivery, potentially enhancing treatment efficacy and reducing systemic toxicity.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
